Pierce Kristen N, Clarke Kim, Swanson Marci M, Hobbs Deborah
is a Clinical Pharmacy Specialist at St. Joseph's/Candler Health System in Savannah, Georgia. At the time the article was written she was a PGY-1 Pharmacy Resident at the Carl Vinson Veterans Affairs Medical Center in Dublin, Georgia. is a Clinical Pharmacy Specialist, Acute Care/Antimicrobial Stewardship; is a Clinical Pharmacist Practitioner and the PACT Clinical Pharmacy Supervisor and PGY-1 Pharmacy Residency Coordinator; is the Associate Chief of Clinical Pharmacy Services and PGY-1 Pharmacy Residency Director; all at the Carl Vinson Veteran Affairs Medical Center.
Fed Pract. 2021 Sep;38(9):426-430. doi: 10.12788/fp.0173. Epub 2021 Sep 12.
Increasing prevalence of antibiotic resistance is an urgent public health threat. The purpose of this project is to implement a pharmacist-managed culture review service to decrease and prevent inappropriate use of antibiotics. This service will intervene in cases of mismatched antibiotic-bacteria combinations to decrease health care provider (HCP) and nursing interruptions, improve patient outcomes, and enhance prescribing practices to reduce occurrence of antibiotic resistance.
Patients requiring changes in antibiotic therapy after culture and susceptibility results were identified through the electronic health record. After results were returned, pharmacists assessed the antibiotic for appropriateness. If the isolated organism was not susceptible to the empiric antibiotic, the pharmacist adjusted the regimen, counseled the patient, documented the intervention electronically, and notified the HCP via an electronic note. Follow-up phone calls assessed for adverse effects and answered patient questions. Pharmacists could change antibiotic therapy without contacting HCPs because of an antimicrobial stewardship care coordination agreement between HCPs and pharmacists. Previously, HCPs were responsible for evaluating culture and susceptibility results as well as adjusting antimicrobial regimens. After implementing this project, 10 interventions were made out of 320 patients from August 2019 to February 2020.
Appropriateness of antibiotic therapy through antimicrobial stewardship could help combat the significant public health issue of antibiotic resistance.
抗生素耐药性的日益普遍是一项紧迫的公共卫生威胁。本项目的目的是实施一项由药剂师管理的培养物审查服务,以减少和预防抗生素的不当使用。该服务将干预抗生素与细菌组合不匹配的情况,以减少医护人员(HCP)和护理工作的中断,改善患者预后,并加强处方规范以减少抗生素耐药性的发生。
通过电子健康记录识别出在培养和药敏结果出来后需要更改抗生素治疗的患者。结果返回后,药剂师评估抗生素的合理性。如果分离出的病原体对经验性使用的抗生素不敏感,药剂师会调整治疗方案,对患者进行咨询,以电子方式记录干预情况,并通过电子记录通知医护人员。后续电话随访评估不良反应并回答患者问题。由于医护人员与药剂师之间达成了抗菌药物管理护理协调协议,药剂师可以在不联系医护人员的情况下更改抗生素治疗方案。以前,医护人员负责评估培养和药敏结果以及调整抗菌治疗方案。在实施本项目后,2019年8月至2020年2月期间,在320例患者中进行了10次干预。
通过抗菌药物管理来确保抗生素治疗的合理性有助于应对抗生素耐药性这一重大公共卫生问题。